Wed, Jul 23, 2014, 8:33 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Sanofi Message Board

biotech_invest 128 posts  |  Last Activity: 2 hours 17 minutes ago Member since: Mar 5, 1998
  • Reply to

    Sehr gut! Somebody is heating PRAN on no news

    by biotech_invest Jun 27, 2014 11:05 AM
    biotech_invest biotech_invest Jun 27, 2014 11:20 AM Flag

    naive idiot lol!
    for phase III HD they need very big money. $7M it's only for management and new director salaries.
    HD phase III (300-400 patients double-blind and etc) required at least $30M.

    MELBOURNE, AUSTRALIA--(Marketwire - Mar 27, 2013) - Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT), today announced that it has secured funding of A$7 million through a placement of approximately 35.9 million fully paid ordinary shares at a price of A$0.195 per share (equivalent to approximately US$2.03 per Nasdaq listed ADR).

    keep pumping please. I need it for this short run up today. Then I will short PRAN at $3 and wait for huge dilution.

  • I will make some money (on day trade only) and then will wait for a dilution announcement. PRAN management needs money for trials (HD at least) so they bring some surprise to PRAN holder: "we are diluting the stock with only one purpose: to finance future phase III HD trial... Don't worry guys, after trial results releasing (something in 2016) you will be compensated by increased pps"
    So GL PRAN longs and wait for next surprise from Dr. Tanzi and his cronies.

  • biotech_invest biotech_invest Jun 24, 2014 5:30 PM Flag

    I think the answer will simple if you use Occam's razor principle.
    Why shorts are not afraid of possible huge losses?
    Because they are playing with their client's money. Portfolio managers shorted MNKD together with other numerous companies and even if short squeeze happens other short positions will compensate MNKD losses. Thus, most likely that they will never cover. If you are portfolio manager of fund that specializing on shorting stocks only you should never cover short positions before company binary event. For investing funds that buy stock it's opposite strategy: buy, hold and never sell even if the stock fall.
    I'm sure that individual investors are not shorting MNKD: they will get margin calls each day with demands to cover or add more cash to account. Short funds are not getting margin calls.
    It's only hypothesis of course. We will see short interest for June 30 on July 10 - 5 days before PDUFA. I'll not be surprised if it increase to 70M.

    Sentiment: Strong Buy

  • biotech_invest biotech_invest Jun 12, 2014 11:19 AM Flag

    come on, guys. Why you are so malicious and sarcastic on each other. PRAN was a perfect opportunity to earn money. And it continues to be such opportunity (still on my radar). Question is when wise investor should sell profitable stock: 100% gain, 200% gain or never?
    If this investor fall in love with this stock the answer is always "never". If he knows that company is a fake the answer will be 100-200% and then short at high before binary event.
    For example now I have almost 100% gain (not-realized) with MNKD and binary event (PDUFA) at July 15. And I know (100%) that this company is not a fake and drug will be a blockbuster. Of course I will not sell MNKD before event.
    Same situation was with PRAN - some investors "knew" that PRAN PBT2 is a blockbuster and they never sell PRAN even when they had 400% gain.
    So problem is in real knowledge about company technology: investor must be sure that biotech that he is invested money is not a fake and its technology is based on real science.
    Only this strategy allow me to be always profitable in biotech during last 5 years.
    Look at my twit about CLSN before crash (below) and then on my comments at website: firstly I was really impressed CLSN technology but then after critical analysis I assumed that their technology is not so perfect and trial will fail with very high probability. BTW even CLSN insiders never sell CLSN before crash and partner gave them non-refundable $5M upfront before trial release.
    I got some gain with CLSN and avoid big losses because I "cracked" their technology and concluded that it's not perfect as company advertised it.

    GL with biotech investment. And don't be stubborn.

    BiotechInvest ‏@Biotech_Invest 14 Sep 2012
    09/14/12: closed CLSN positions (it's too risky: treated group results might be equal to placebo group).

  • biotech_invest biotech_invest Jun 11, 2014 11:24 PM Flag

    Best day for MNKD drug approval will be July 3 (Thursday) after market and better with halt :-)
    Just imagine how shorts will celebrate July 4th (they will never forget it).
    FDA should do it as an excuse for several CRLs that delayed Afreeza for several years.
    Unfortunately FDA officers are too pragmatic and soulless - most probably they will approve MNKD drug just in time :-(
    GL and keep MannKind tight

    Sentiment: Strong Buy

  • and the reason is simple: both MNKD and NVO are using carrier molecules for insulin delivery. Both MNKD and Novo bought these carrier from Emisphere: MNKD for lung delivery of insulun and other biologics; Novo for oral delivery of GLP-1 and insulin. Looks like that Novo oral GLP-1 and insulin failed to show good results but MNKD lung insulin (and potentially GLP-1, basal insulin and etc.) is very successful. Novo scientists knows now how EMIS carriers are working (safety, efficacy, weakness and etc.) and also they know that MNKD's Afrezza is just an insulin co-dried with EMIS carrier. Actually this carrier may be combined with any therauputic protein or peptide and lung bioavailability will be very high.
    Conclusion: NVO will buy MNKD or partner MNKD insulin/GLP-1 pipeline with very high probability.

    Sentiment: Strong Buy

  • 5/30/2014 68,246,601 11,207,127 6.089571
    5/15/2014 68,035,239 6,058,257 11.230167

    seems like shorts will have D-day

    Sentiment: Strong Buy

  • LOL! So many desperate attempts to crash MNKD pps and buy shares from "weak hands". The short interest (5/30/14) will show who is ordering MNKD basher's paper in SA and MF. TheStreet AF looks exhausted with ideas what is next argument for MNKD immediate selling.
    BTW FDA may approve MNKD before July 4th (vacation time, long holiday and etc.). Thursday July 3 AM will be the best day to roast shorts. They will remember such ID forever.
    GL and hold MNKD strongly.

    Sentiment: Strong Buy

  • NAVB: Lymphoseek® (technetium Tc 99m tilmanocept) Injection is a novel, receptor-targeted, small-molecule radiopharmaceutical used in lymphatic mapping procedures that are performed to help in the diagnostic evaluation of potential cancer spread for patients with breast cancer and melanoma.
    EDAP: Ablatherm(R) for high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment
    EDAP cap should be at least 259M (after positive vote and approval) so pps will be $12 - huge potential for small cap biotech and very rare opportunity. So, I'm in.

    Sentiment: Strong Buy

  • 5/15/2014 19,779,105 924,791 21.387649

    IDIX shorts were just roasted alive today.
    MNKD shorts are even in more danger: MNKD may jump 100% on FDA approval and sold or partnered i.e. second pps jump 100%
    with 68M shorted shares these 2 events will be devastating for shorts.
    We will see in a couple days will they (shorts) continue to be stubborn or already start to cover.
    GL to MNKD longs

    Sentiment: Strong Buy

  • Reply to

    Jefferies presentation by Nadav

    by larryharry2012 Jun 3, 2014 4:09 AM
    biotech_invest biotech_invest Jun 9, 2014 9:10 AM Flag

    Are you really believe in everything that Kidrons said on numerous presentations?
    In this case it's exactly for you:
    “It is the mark of an educated mind to be able to entertain a thought without accepting it.” Aristotle Quotes
    Kidrons fooled investors like you with only one purpose - to become rich. Oral insulin is very hard target and Kidrons (even with Arbit help) can't crack it. But you also can be rich if you know about it.
    Scam biotechs are very profitable (sometimes even more than biotech gems).

  • Reply to

    Jefferies presentation by Nadav

    by larryharry2012 Jun 3, 2014 4:09 AM
    biotech_invest biotech_invest Jun 3, 2014 6:30 PM Flag

    Indeed, ORMP is a perfect scam biotech for playing.
    Of course, that 0801 will be safe and have zero hyperglycemic events at night time. Because of close to zero bioavailability of oral insulin. ORMP will be pumped on these "new and significant data" and it will be perfect time to make money on this scam biotech. Founders (mother and son) are already rich but they need some time to leave (to have happy life) without lawsuits initiated by fooled investors.

    Sentiment: Strong Sell

  • it's still delayed at NASDAQ.
    shorts must start to cover their positions 2 weeks ago. After $10 (next week) they will be roasted. FDA approval will be "sudden death" event (i.e. before July 15) and not covered shorts will be completely crashed.
    GL to MNKD technology believers.

    Sentiment: Strong Buy

  • Reply to

    Just to keep the board informed

    by esoteric687 Jun 1, 2014 8:47 PM
    biotech_invest biotech_invest Jun 2, 2014 11:17 AM Flag

    so you didn't sell PRAN on Friday and even bought it? You' re sick if you did it.
    It was just a short and predictable spike and all sober and wise investors used it to make some money. May is ended and the summer time is not good for investment in biotechs (especially in scam ones). Only MNKD is good now (PDUFA date is coming).
    Next spike for PRAN has very low probability in next 2-3 months. So you will lose your money (PRAN pps will go to $1-1.50 during summer time).
    GL and don't be so stubborn

    Sentiment: Strong Sell

  • Reply to

    Crowd psychology

    by goutah3006 May 28, 2014 12:16 PM
    biotech_invest biotech_invest May 28, 2014 1:11 PM Flag

    finally some wise voice...
    we are here (in biotech investment) to make money. We should avoid losses and be "burned" by both biotech scams and gems.
    Forget about PRAN "science" and their "universal drug" for HD/AD and use PRAN volatility to have a gain. But if you need HD/AD drugs right now you shouldn't invest in small and micro cap biotechs (investment needs very fast actions and quickness of wit).

  • biotech_invest biotech_invest May 28, 2014 10:43 AM Flag

    come one guys, I'm not against PRAN investors I'm helping them to avoid big losses with PRAN (again). It's just my strategy. Yesterday I twitted:
    05/27/14: PRAN runs up again (on no news, so it's "investomadness" event); will buy it and then sell at high ($2-3) and short.
    So, I bought PRAN and will keep it up to $2.5-3 (end of week). Then sell it and wait for a right moment to short it.
    Prediction for $0.15 is still in force (for long term investment).
    If you are biotech investor you must be flexible: never fall in love with stock, never hate a stock, just make money on both scams and gems.
    I'm thinking about to buy even ORMP now - for short run up (just waiting for volume). Why not?

  • but for highest gain you need to exit before next crash. Question is how you know when this crash happen?
    If no news (and PRAN was "surging despite a lack of any significant news regarding the company") crash happens after 3-4 days. The reason is simple: smartest investors will start to sell and get gain and even short this scam to have maximum gain.
    So, Thursday-Friday are days to short PRAN at high.

  • biotech_invest biotech_invest May 27, 2014 2:26 PM Flag

    come on, shorts were covered long time ago.
    should be some news - next HD trial, licensing or etc.

  • biotech_invest by biotech_invest May 27, 2014 2:09 PM Flag

    why not use it again and make some money?
    Buy, sell at high (this time around $2-2.5) and short.

  • biotech_invest biotech_invest May 23, 2014 10:38 AM Flag

    "Fell in Love with Prana"... May it's time to visit psychiatrist?
    Definitely, a "falling in love with biotech company (especially scam one it's a symptom of some mental disorder. Most likely it's simple senile (not AD). Or may be it's PRANAnoia?
    you have 298 posts | Last Activity: Apr 18, 2014 2:08 AM
    Member since: Jan 16, 2013
    May be it's too much? Get some rest, short PRAN and wait for PRAN pps

    Sentiment: Strong Sell

51.95+0.13(+0.25%)Jul 23 4:02 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.